Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:milnacipran
|
| gptkbp:approvalYear |
2009
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
N06AX17
|
| gptkbp:CASNumber |
92623-87-1
|
| gptkbp:chemicalFormula |
C15H22N2O
|
| gptkbp:contraindication |
uncontrolled narrow-angle glaucoma
|
| gptkbp:drugClass |
norepinephrine reuptake inhibitor
|
| https://www.w3.org/2000/01/rdf-schema#label |
Savella
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Forest_Laboratories
|
| gptkbp:pregnancyCategory |
C
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
constipation dizziness headache insomnia |
| gptkbp:synonym |
gptkb:milnacipran_hydrochloride
|
| gptkbp:usedFor |
fibromyalgia
|
| gptkbp:bfsParent |
gptkb:Forest_Laboratories
gptkb:Milnacipran |
| gptkbp:bfsLayer |
7
|